Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates

Matthew R Allen1

  • 1Department of Anatomy and Cell Biology, Indiana University School of Medicine, 635 Barnhill Drive, MS-5035, Indianapolis, IN 46202, USA.

Insights

Medication-related osteonecrosis of the jaw (MRONJ) emerged as a concern with bisphosphonates. This review covers basic science and animal studies on MRONJ, guiding future research directions.

Area of Science:

  • Oral and Maxillofacial Surgery
  • Pharmacology
  • Bone Biology

Background:

  • Bisphosphonates, crucial for metabolic bone disease, were linked to osteonecrosis of the jaw (ONJ) in the early 2000s.
  • Medication-related ONJ (MRONJ) now encompasses agents beyond bisphosphonates, though understanding has progressed slowly.
  • Significant concern arose from the association between bisphosphonates and ONJ, impacting clinical practice.

Purpose of the Study:

  • To review fundamental basic science research on MRONJ.
  • To analyze translational (animal) studies investigating MRONJ.
  • To identify key areas for future research in MRONJ.

Main Methods:

  • Literature review of basic science studies.
  • Analysis of translational research in animal models.
  • Synthesis of current knowledge on MRONJ pathogenesis.

Main Results:

  • Highlights significant findings from basic science investigations into MRONJ.
  • Summarizes outcomes from animal model studies relevant to MRONJ.
  • Identifies gaps in current understanding and research.

Conclusions:

  • Basic science and translational studies are crucial for advancing MRONJ knowledge.
  • Further research is needed to fully elucidate MRONJ mechanisms.
  • The field requires focused investigation to address remaining challenges in MRONJ.